Metabolic Improvements and Weight Trajectories After Metabolic-Bariatric Surgery in Women with Polyendocrine Metabolic Ovarian Syndrome

• by Lei Zhang, Xihan Li, Shiyan Zhang, Bojun Zhou, Boyi Hu, YiLin Gai, Chaojun Wang, Guoqing Yang, Hua Meng

• September 5, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Immunological mechanisms of low-grade systemic inflammation and its role in endometrial dysfunction in women with polycystic ovary syndrome

• by Liuhua Qu, Lu Li, Ling Yang, Ying Liu

• July 9, 2026

Editorial Expression of Concern: Office microlaparoscopic ovarian drilling (OMLOD) versus conventional laparoscopic ovarian drilling (LOD) for women with polycystic ovary syndrome

• by Imaduldin M. Salah

• July 15, 2026